Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Modest success of early cell therapies in HF leaves open true cardiomyocyte regeneration; supports molecular imaging to track repair in future trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Thackeray et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: